Drug Type CAR-T |
Synonyms- |
Target |
Action antagonists |
Mechanism ROR1 antagonists(Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | Canada | 16 Aug 2021 | |
| Lung Cancer | Preclinical | Canada | 16 Aug 2021 | |
| Pancreatic Cancer | Preclinical | Canada | 16 Aug 2021 |





